CHIKUNGUNYA VIRUS
Clinical trials for CHIKUNGUNYA VIRUS explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA VIRUS trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chikungunya vaccine enters first human safety trial
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new vaccine called PepGNP-ChikV, designed to protect against chikungunya virus. About 40 healthy adults aged 18-60 will receive two shots, 42 days apart, and be monitored for safety and immune response for a year. The study aims to see if the vaccin…
Matched conditions: CHIKUNGUNYA VIRUS
Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:31 UTC
-
Major trial launches for first chikungunya vaccine
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests an experimental vaccine to prevent chikungunya, a mosquito-borne virus that causes fever and joint pain. About 6,144 adolescents and adults will receive either the vaccine or a placebo. The goal is to see if the vaccine can stop the disease and reduce long-term j…
Matched conditions: CHIKUNGUNYA VIRUS
Phase: PHASE3 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:50 UTC